Organ damage in sickle cell disease (SCD) is a crucial determinant for disease severity and prognosis. In a previous study, we analyzed the prevalence of SCD-related organ damage and complications in adult sickle cell patients. We now describe a seven-year follow-up of this cohort.
the prevalence of avascular osteonecrosis (from 12.5% to 20.4%), renal failure (from 6.7% to 23 .4%), retinopathy (from 39.7% to 53.8%) was observed in the whole group. In HbSS/HbSb 0 -thal patients also progression in microalbuminuria (from 34% to 45%) and elevated TRV (from 40% to 48%) was observed while hardly any progression in the prevalence of cholelithiasis, priapism, stroke or chronic ulcers was seen. The proportion of patients with at least one episode of ACS increased in the group of HbSS/HbSb 0 -thal patients from 32% to 49.1%. In conclusion, 62% of the sickle cell patients in this prospective cohort study developed a new SCD-related complication in a comprehensive care setting within 7 years of follow-up. Although the hospital admission rate for VOC remained stable, multiple forms of organ damage increased substantially. These observations underline the need for continued screening for organ damage in all adult patients with SCD.
| I N T R O D U C T I O N
Sickle cell disease (SCD) is one of world's most common hereditary diseases. Since the first sickle cell patient was described over 100 years ago, 1 a number of successful interventions in the treatment of mostly children with SCD have been developed. Nowadays the median life expectancy has reached the fifth decade of life and over 98% of the children with SCD will reach adulthood in Western societies. 2 Unfortunately, recently reported life expectancy in adult patients with SCD did not show any improvement in the last decades. 3 Traditionally disease severity and quality of life for sickle cell patients are defined by the frequency of vaso-occlusive crisis (VOC). 4 Frequency of VOC and the occurrence of organ damage are crucial determinants for medical treatment in SCD. 2, 5, 6 In a previous study, we systematically analyzed the prevalence of SCD related organ damage and complications in a cohort of adult sickle cell patients in a tertiary teaching hospital in the Netherlands. We demonstrated that the majority of sickle cell related forms of organ damage are not related with the rate of admission for VOC but it is unclear what the progression of these different forms of organ damage is. 7 In the current study, we describe the seven-year follow-up of this patient cohort, to provide insight in the course of the various forms of organ damage and SCD related complications. Secondarily, we aimed to determine prognostic factors for the development of organ damage in this patient cohort. 13 Stroke was defined as a diagnosis of clinical overt stroke confirmed by MRI or computerized tomography. Priapism was defined as a history of priapism requiring treatment in the hospital or a history of multiple episodes (2) needing consultation at the outpatient's clinic.
| M E T H O D S
Acute chest syndrome was defined as the finding of a new pulmonary infiltrate on chest radiography in combination with fever, respiratory symptoms, or chest pain for which medical treatment was needed.
14 VOC was defined as the occurrence of pain in the extremities, back, abdomen, chest, or head that led to a clinic visit and could not be explained otherwise. 4 Alpha-thalassemia screening was performed with a multiplex PCR assay. 15 
| S T A T I S T I C A L A N A L Y S I S

| R E S U L T S
Of all originally included patients (N 5 104), nine were lost to follow- presented in Table 2 . We found no relation between admission rate and the development of any form of organ damage with the exception of iron overload and ACS which were more often observed in most frequently admitted patients. There were ten patients with > 2 crises per damage: avascular osteonecrosis (from 8% to 14%), retinopathy (from 61% to 76%) and renal failure (from 5% to 29%). Furthermore, the use of hydroxycarbamide increased slightly in both genotype groups (HbSS from 25% to 31% and HbSC from 5% to 13%). (Table 3) The frequency of admissions for VOC remained stable for both genotype groups over the observed period. Cross sectional analysis
shows that 90% of our cohort has at least one form of chronic organ damage at the end of the follow up period. 
| DISCUSSION
Cumulating sickle cell related organ damage is an important determinant of disease severity in adult patients with sickle cell disease. However, for most forms of organ damage the rate of progression has not been assessed prospectively. In the present study, we describe the progression of organ damage over a period of seven years in a predefined prospectively followed cohort of adult sickle cell patients in a comprehensive care setting in the Netherlands.
Our data show that the development of organ damage is an ongoing process in adult sickle cell patients. The cross sectional analysis shows that 80% of our cohort has at least one form of sickle cell related organ damage and more than half of the population has years. 23 In line with that study hardly any patients developed end stage renal failure in our cohort despite the decrease in GFR during the observation period .
Prevalence of avascular necrosis in our patients increased from
12.5% at baseline to 20.4% after 7 years of follow up. Patients with a more severe genotype more often developed this complication as compared to the patients with a milder genotype. The prevalence of this complication varies enormously in different studies, mostly due to whether only symptomatic patients or also asymptomatic patients were screened for this complication. In our cohort, only patients with symptoms suspect for avascular osteonecrosis were evaluated by imaging. In a large cross-sectional study by Milner et al. the prevalence of avascular necrosis of the hip was 18.8% in the group between 25 and 34 years of age which is within the range we observed. 24 There are no prospective studies on the progression rate of avascular osteonecrosis in SCD.
Retinopathy was found in 38% (HbSS/HbSb 0 -thal) and 76%
(HbSC/HbSb 1 -thal) of our patients in the final analysis after 7 years of follow up. The difference in prevalence per genotype is in line with previous observations. Although the prevalence is higher as compared to previous studies this might be explained by the mean age of our cohort as compared to most studies in children. In a large cohort of patients described by Downes et al proliferative retinopathy started at the age of 10 years and 18 years for patients with HbSC and HbSS, respectively and rose to a prevalence of 43% and 14%, respectively, at the age of 25. 25 Another possible explanation for the rather high prevalence we found might be the fact that we scored all forms of retinopathy in our cohort. In a recent study the most important risk factors for retinopathy were found to be HbSC genotype and age > 35 years comparable with the observations in our cohort. 26 Elevated TRV increased from 33.3% at baseline in 2006 to 37% in all patients at the final assessment after seven years of follow up. Given the median age of our cohort at the final analysis this is comparable to what has described in several cross-sectional previous study cohorts ranging from 27% to 33%. 5, 11, 27 Progression in the prevalence of elevated TRV was mainly observed in the patients with HbSS/HbSb 0 . Iron Overload 10.6% (n 5 11) 17.2% (n 5 11) 0 13.6% (n 5 12) 20.0% (n 5 11) 3.0% (n 5 1)
Prevalence of priapism in our cohort is lower (11.5%) as compared to the prevalence of 35% described in the literature. 28, 29 This is most likely related to the mean age of the male population. In general, the peak incidence of priapism is in adolescents and young adults. In line with this observation no new cases were observed during the 7 year follow up in our cohort. In addition, differences in methods (medical charts, self-reported complains, questionnaires and diaries) may have an effect on the incidence rate.
Chronic leg ulcers were found in 8.7% of the patients at baseline and increased to 11.4% seven years later. In the literature large differences in prevalence of chronic leg ulcers can be found with prevalence rates as high as 30-70% in studies from Jamaica 30,31 whereas the Cooperative Study in the US found a prevalence rate of 5%. 13 In a recent report of Minniti et al. a prevalence of 21.4% in HbSS patients and 9.6% in HbSC patients was observed 32 which equals the prevalence in our cohort. Importantly, our present study confirms our previous observation that there is no relation between admission rate for VOC and the presence of most forms of SCD related organ damage. 7 Furthermore, the risk of developing any new form of organ damage does not differ between patients in whom organ damage was not manifest at baseline evaluation and patients who already had some form of organ damage.
We were not able to find clustering of specific forms of organ damage in our patient cohort although this might be due to the limited number of patients included. Our observations reinforce the importance to systemically screen for organ damage in all patients with SCD regardless of genotype and clinical presentation. This is important since sickle cell patients without VOC are often considered to have a mild disease.
Achieving a satisfactory compliance to outpatient clinic appointments remains a great challenge for many clinicians in the care for sickle cell patients, which may be even more challenging in sickle cell patients without VOC. For that reason, it is highly recommended to integrate special patient programs into standard care to improve compliance.
Hydroxyurea was used by 30% of our patients, this represents a minority of patients with a severe form of SCD. Indications for HU prescription in 2007 were frequent admissions with painful crises and severe anemia. In 2014, the guidelines were indeed broadened to all patients with frequent painful episodes and a history of ACS. The proportion of patients using HU in our center has increased since these changes in the guidelines. In our study, no effect of HU use was found on organ damage progression, which might be explained by the fact that the most severe sickle cell patients received HU and were therefore more likely to develop new organ damage. The effect of HU on organ damage can only be assessed in a prospective randomized controlled trial and is difficult to assess retrospectively. Interestingly in the Baby hug trial only a moderate effect on concentration capacity of the kidneys was found, while no effect on GFR was observed. In other cohort studies varying effects on renal function were observed. 33 The lack of effect of HU on organ damage in our study can therefore be explained by the retrospective design. In line with this, a recent metaanalysis, found no association between the use of HU and mortality in adult patients with sickle cell disease underlining the need for prospective trials to address these questions. 34 We have to address some limitations in this study. We included elevated TRV as a form of organ damage in our study, as previously this was thought to be a reliable marker for pulmonary hypertension.
However, a recent study showed that only 25% of the patients with a TRV > 2.5 m/s actually suffer from pulmonary hypertension. 11 Nevertheless, an elevated TRV (>2.5 m/s) has been associated with early mortality in SCD in several studies, 5, 11, 35 while others were unable to reproduce this. 36 Still, we think it is of importance to carefully followup patients with elevated TRV. 37 In a recently published guideline, right heart catheterization is advised in patients with a TRV >2.9 m/s or clinical symptoms of pulmonary hypertension. 38 Iron overload was in our study defined as a ferritin >1000 mg/L and a transfusion history of 20 units of blood or more. In eight out of ten cases with iron overload, diagnosed by this definition, also a heart/liver MRI (T2*) was performed to confirm the diagnosis. In five of these cases iron overload could be confirmed. Therefore, iron overload may have been over diagnosed by the definition used in our study.
Despite these limitations we feel that the prevalence and rate of progression of organ damage in our study cohort of adult sickle cell patients reinforces the need for systematic screening and/or timely detection (like for the occurrence of PHT) of organ damage in order to prevent further deterioration of organ damage affecting both morbidity and mortality of SCD. 
